Day

November 6, 2019
An Interview with Kristin Bedard PhD, Chief Scientific Officer Kineta Immuno-Oncology. KINETA, INC. – Innovation in Cancer Care, Developing (and Investing in) New Drugs in High Need Areas. Part 1 In a previous article, our readers were introduced to your co-founder and Kineta, Inc. CEO Shawn Iadonato.  In that article we shared with our readers...
Read More

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Our Cases